Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner

buir.contributor.authorAtalar, Ergin
dc.citation.epage120en_US
dc.citation.issueNumber1en_US
dc.citation.spage113en_US
dc.citation.volumeNumber175en_US
dc.contributor.authorSusil, R. C.en_US
dc.contributor.authorMenard, C.en_US
dc.contributor.authorKriegel, A.en_US
dc.contributor.authorColeman, J. A.en_US
dc.contributor.authorCamphausen, K.en_US
dc.contributor.authorChoyke, P.en_US
dc.contributor.authorFichtinger, G.en_US
dc.contributor.authorWhitcomb, L. L.en_US
dc.contributor.authorColeman, C. N.en_US
dc.contributor.authorAtalar, Erginen_US
dc.date.accessioned2015-07-28T11:57:54Z
dc.date.available2015-07-28T11:57:54Z
dc.date.issued2006-01en_US
dc.departmentDepartment of Electrical and Electronics Engineeringen_US
dc.description.abstractPurpose: We investigated the accuracy and feasibility of a system that provides transrectal needle access to the prostate concurrent with 1.5 Tesla MRI which previously has not been possible. Materials and Methods: In 5 patients with previously diagnosed prostate cancer, MRI guided intraprostatic placement of gold fiducial markers (4 procedures) and/or prostate biopsy (3 procedures) was performed using local anesthesia. Results: Mean procedure duration was 76 minutes and all patients tolerated the intervention well. Procedure related adverse events included self-limited hematuria and hematochezia following 3 of 8 procedures (all resolved in less than 1 week). Mean needle placement accuracy was 1.9 mm for the fiducial marker placement studies and 1.8 mm for the biopsy procedures. Mean fiducial marker placement accuracy was 4.8 mm and the mean fiducial marker placement accuracy transverse to the needle direction was 2.6 mm. All patients who underwent the procedure were able to complete their course of radiotherapy without delay or complication. Conclusions: While studies of clinical usefulness are warranted, transrectal 1.5 T MRI guided prostate biopsy and fiducial marker placement is feasible using this system, providing new opportunities for image guided diagnostic and therapeutic prostate interventions.en_US
dc.description.provenanceMade available in DSpace on 2015-07-28T11:57:54Z (GMT). No. of bitstreams: 1 10.1016-S0022-5347(05)00065-0.pdf: 965310 bytes, checksum: 56def07cef7945bc8452ab53d9a447d8 (MD5)en
dc.identifier.doi10.1016/S0022-5347(05)00065-0en_US
dc.identifier.eissn1527-3792
dc.identifier.issn0022-5347
dc.identifier.urihttp://hdl.handle.net/11693/11493
dc.language.isoEnglishen_US
dc.publisherElsevier Inc.en_US
dc.relation.isversionofhttps://doi.org/10.1016/S0022-5347(05)00065-0en_US
dc.source.titleThe Journal of Urologyen_US
dc.subjectMagnetic resonance imagingen_US
dc.subjectProstateen_US
dc.subjectProstatic neoplasmsen_US
dc.subjectBiopsyen_US
dc.subjectRadiologyen_US
dc.subjectInterventionalen_US
dc.titleTransrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanneren_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Transrectal Prostate Biopsy and Fiducial Marker Placement in a Standard 1.5T Magnetic Resonance Imaging Scanner
Size:
942.69 KB
Format:
Adobe Portable Document Format
Description:
Full printable version